Search
for
Sort by
Research 31–60 of 123
- Contemporary drug synthesis
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis
- Lower urinary tract symptoms (LUTS): The role of medications in improvement of quality of life
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Adverse effects of common medications on male fertility
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Ottawa, Ontario, Canada, February 13–16, 2013
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Identification of Potential Cytochrome p450c 17 Alpha Inhibitors for the Treatment of PCOS via Scaffold Hopping and Fragment-Based De-Novo Drug Design
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Diseases of the Canine Prostate Gland
- Dutasteride
- Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
- Nitric Oxide Signal Transduction and Its Role in Skin Sensitization
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- From bench to babies – drug development for male subfertility
- Novel effect of sildenafil on hair growth